Eileen M. O’Reilly, MD, discusses the potential of tumor treating fields for the treatment of patients with locally advanced pancreatic cancer.
Eileen M. O'Reilly, MD
Advertisement
Eileen M. O’Reilly, MD, is the Winthrop Rockefeller Endowed Chair of Medical Oncology and section head of hepatopancreaticobi at Memorial Sloan Kettering Cancer Center, as well as codirector of medical initiatives at the David M. Rubenstein Center for Pancreatic Cancer Research, in New York.
Articles by Eileen M. O'Reilly, MD
Eileen M. O’Reilly, MD, discusses the rapidly evolving role of local therapy in the management of advanced/metastatic pancreatic cancer.
Eileen M. O'Reilly, MD, discusses survival outcomes from the phase 3 NAPOLI 3 trial in patients with metastatic pancreatic ductal adenocarcinoma.
Eileen O'Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center, discusses the role of immunotherapy in patients with pancreatic cancer.
Advertisement
Latest Updated Articles
Dr. O'Reilly on Immunotherapy in Pancreatic CancerPublished: January 8th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5